CORE ADANIPORTS+0.24% BIRET-0.24% BRIGADE-0.85% DLF-1.17% EMBASSY+1.10% GMRAIRPORT+0.00% GODREJPROP+0.19% IRB+3.46% LODHA-0.98% LT-1.76% MAHLIFE-1.64% MINDSPACE-1.39% NCC-0.64% OBEROIRLTY-0.14% PHOENIXLTD+0.11% PRESTIGE-0.22% SOBHA+0.95% as of 2026-08-26 14:06 UTC

The Annexure

Desk› Healthcare› Gland Pharma Ltd

Gland Pharma Ltd

BSE 543245 GLAND INE068V01023
Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals NIFTY 500

Filing rhythm · 30 trading days

25 filings · 10 material · busiest 2026-08-10

What it files

Press Release3 Analyst / Investor Meet3 AGM / EGM2 Newspaper Publication2 General2 Postal Ballot2 Concall Transcript1 Change in Management1

Filings

25 in the window

  1. 25 August 2026

    AGM / EGM

    Shareholder Meeting / Postal Ballot-Outcome of AGM

    48th AGM Outcome

    AGM/EGM / AGM View filing →

  2. 17 August 2026

    Concall Transcript

    Earnings Call Transcript

    Q1FY27 Earnings Call Transcript

    Company Update / Earnings Call Transcript View filing →

  3. 14 August 2026

    Change in Management

    Change in Management

    Appointment of Chief Executive Officer of the Company

    Company Update / Change in Management View filing →

  4. 11 August 2026

    Newspaper Publication

    Newspaper Publication

    Newspaper Publication on Q1FY27 Financial Results

    Company Update / Newspaper Publication View filing →

  5. 10 August 2026

    Results

    Unaudited Financial Results For The Quarter Ended June 30, 2026

    Unaudited Financial results for the quarter ended June 30, 2026

    Result / Financial Results View filing →

  6. 10 August 2026

    Board Outcome

    Board Meeting Outcome for Unaudited Financial Results For The Quarter Ended June 30, 2026

    Outcome of Board Meeting

    Board Meeting / Outcome of Board Meeting View filing →

  7. 10 August 2026

    Press Release

    Press Release / Media Release

    Press release on Q1FY27 Financial Results

    Company Update / Press Release / Media Release View filing →

  8. 10 August 2026

    Investor Presentation

    Investor Presentation

    Investor Presentation on Q1FY27 Financial Results

    Company Update / Investor Presentation View filing →

  9. 10 August 2026

    Analyst / Investor Meet

    Analyst / Investor Meet - Intimation

    Schedule of Investor Meets

    Company Update / Analyst / Investor Meet View filing →

  10. 10 August 2026

    Analyst / Investor Meet

    Analyst / Investor Meet - Outcome

    Q1FY27 Earnings Call Audio recording

    Company Update / Analyst / Investor Meet View filing →

  11. 5 August 2026

    Press Release

    Press Release / Media Release

    Gland Pharma announces strategic collaboration with Neuland Laboratories for sterile API Manufacturing

    Company Update / Press Release / Media Release View filing →

  12. 31 July 2026

    AGM / EGM

    Notice Of 48Th AGM

    Notice of 48th AGM

    AGM/EGM / AGM View filing →

  13. 31 July 2026

    Annual Report

    Reg. 34 (1) Annual Report.

    Annual Report for the FY 2025-26

    Others / Reg. 34 (1) Annual Report View filing →

  14. 31 July 2026

    BRSR

    Business Responsibility and Sustainability Reporting (BRSR)

    BRSR Report for the year ended March 31, 2026

    Others / Business Responsibility and Sustainability Reporting (BRSR) View filing →

  15. 31 July 2026

    General

    Letter To Shareholders

    Letter to Shareholders regarding dispatch of 48th AGM Notice and Annual report for the FY 2025-26

    Company Update / General View filing →

  16. 30 July 2026

    Fundraising

    Issue of Securities

    Grant of Stock Options under Gland Pharma Employee Stock Option Scheme, 2025

    Company Update / Issue of Securities View filing →

  17. 30 July 2026

    ESOP Allotment

    Allotment of ESOP / ESPS

    Allotment of Equity Shares under ESOPS

    Company Update / Allotment of ESOP / ESPS View filing →

  18. 29 July 2026

    Press Release

    Press Release / Media Release

    Gland Pharma receives approval for Suggamadex Injection

    Company Update / Press Release / Media Release View filing →

  19. 28 July 2026

    Newspaper Publication

    Newspaper Publication

    Copy of News Paper Publication

    Company Update / Newspaper Publication View filing →

  20. 24 July 2026

    Board Meeting

    Board Meeting Intimation for Declaration Of Unaudited Standalone And Consolidated Financial Results For The Quarter Ended June 30, 2026

    Gland Pharma Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/08/2026 ,inter alia, to consider and approve Unaudited Standalone and Consolidated ....

    Board Meeting / Board Meeting View filing →

  21. 24 July 2026

    Analyst / Investor Meet

    Analyst / Investor Meet - Intimation

    Q1FY27 Earnings Call Intimation

    Company Update / Analyst / Investor Meet View filing →

  22. 20 July 2026

    Postal Ballot

    Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot

    Postal Ballot Outcome

    AGM/EGM / Postal Ballot View filing →

  23. 20 July 2026

    Postal Ballot

    Shareholder Meeting / Postal Ballot-Scrutinizer"s Report

    Scrutinizers Report on the Postal Ballot

    AGM/EGM / Postal Ballot View filing →

  24. 20 July 2026

    Change in Directorate

    Change in Directorate

    Reappointment of Mr. Vetter and Appointment of Mr. Keller as Independent Directors of the Company

    Company Update / Change in Directorate View filing →

  25. 16 July 2026

    General

    Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

    Intimation of Order passed by the Customs Authority

    Company Update / General View filing →